Aptevo Therapeutics (APVO) Non-Current Debt (2016 - 2022)
Aptevo Therapeutics (APVO) reported Non-Current Debt of $1.46 million for Q4 2022, down 60.7% from $3.71 million a year earlier and down 23.8% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Non-Current Debt (2016 - 2022) Analysis & Trends
Dating back to Q3 2016, Aptevo Therapeutics' Non-Current Debt record includes 22 quarters.
- Non-Current Debt has a five-year compound annual growth rate of -37.9% (FY2017 to FY2022).
- By year, Non-Current Debt came in at $3.71 million in FY2021 (-81.5%), $20.05 million in FY2020 and $19.28 million in FY2018 (+22.6%).
- The Q4 2022 figure ranks as the lowest quarterly Non-Current Debt in data going back to Q3 2016.
- Year over year, Non-Current Debt has now declined in each of the last six quarters, with an average decline of 60.6% over the last six quarters.
- The high point for year-over-year Non-Current Debt in five years was Q1 2019 (growth of 38.9%); the low point was Q3 2021 (a decline of 84.1%).
- Per Business Quant data, the three quarters before Q4 2022 came in at $1.91 million (Q3 2022), $2.36 million (Q2 2022) and $2.8 million (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.38 Bn | 1,098.96 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 613.84 Bn | 532.37 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 502.13 Bn | 475.24 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.76 Bn | 322.14 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.08 Bn | 262.07 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 262.03 Bn | 235.71 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 235.81 Bn | 191.21 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Aptevo Therapeutics | 1.94 Mn | -65.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 3.71 Mn |
| Sep 30, 2021 | 4.01 Mn |
| Jun 30, 2021 | 4.32 Mn |
| Mar 31, 2021 | 4.61 Mn |
| Dec 31, 2020 | 20.05 Mn |
| Sep 30, 2020 | 25.20 Mn |
| Jun 30, 2019 | 19.56 Mn |
| Mar 31, 2019 | 19.42 Mn |
| Dec 31, 2018 | 19.28 Mn |
| Sep 30, 2018 | 19.14 Mn |
| Jun 30, 2018 | 15.40 Mn |
| Mar 31, 2018 | 13.98 Mn |
| Dec 31, 2017 | 15.73 Mn |
| Sep 30, 2017 | 17.48 Mn |
| Jun 30, 2017 | 18.75 Mn |
| Mar 31, 2017 | 18.44 Mn |
API Access
Aptevo Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();